Pipeline

PNV is steadily building an impressive pipeline....


Novosorb BTM (resorbable foam)

• Approved in Australia, UK and EU for repair of lost dermis from any cause, including full thickness burns.
• Approved in US for surgical, trauma and draining wounds, including second degree burns, as well as ulcers - venous, diabetic, chronic and vascular.
• Current sizes - 10x10cm, 10x20cm, 10x40cm
• New sizes imminent – 2x2cm, 5x5cm (chronic wounds); 20x20cm (in selected countries)

Novosorb SynPath (resorbable foam)

• Brand for future use of Novosorb BTM in US chronic wound market (NovoSorb BTM already has regulatory approval for use in all chronic wound applications).
• Unique sizes and shapes for outpatient/community market
• Initiating reimbursement study for diabetic foot ulcers and venous leg ulcers in the US to achieve unique reimbursement code and pricing.

Novosorb SynTrel (resorbable extruded film ultrasonically welded to resorbable foam)

• Designed for hernia repair
• Two products – for intra-peritoneal (SynTrel SS) and retro-muscular placement (SynTrel DS)
• Expected US market entry H2 CY21.

Breast Products (foam and film)

• Two products - breast pocket and 3D breast
• Targeting both aesthetic and reconstructive markets
• In partnership with Establishment Labs

Drug Elution Pellet (polymer beads)

• Examples of tested drugs include contraceptives and steroids.
• To date, has produced polymers with up to 45% weight bound drug.
• Developing technical dossier in preparation for clinical trials.
• Patents awarded
• Intention to license to pharma.

Sports Medicine Product (naked foam)

• Initial design and animal studies conducted in application of tendon and meniscus repair

Surgical Anti-adhesion Barrier (film)